#USA #Veeva Systems #Clinical Trials #IQVIA #Research Triangle Park, NC

IQVIA and Veeva Systems: A New Era of Partnership

On August 18, 2025, IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) announced a groundbreaking collaboration aimed at transforming clinical and commercial efficiencies in the life sciences sector. This partnership not only resolves all outstanding legal disputes between the two companies but also opens the door for a new frontier in how healthcare organizations can harness joint capabilities.

Details of the Partnership

The long-term agreement between IQVIA and Veeva establishes an ecosystem where their respective software, data, and technologies work seamlessly together. This integration grants clients access to enhanced tools for clinical trials and commercial operations. Some key highlights from this partnership include:

• - Master Data Management: Both companies have introduced third-party access agreements, enabling users to incorporate each other's data into their systems. For instance, data from IQVIA can now be effectively utilized within Veeva's Network for managing master data, while Veeva's analytics capabilities can be harnessed within IQVIA’s commercial products.

• - Clinical Trial Execution: As part of Veeva's CRO Clinical Data Partner program, IQVIA will leverage the Veeva Clinical Suite. This collaboration will facilitate better execution of clinical trials, speeding up processes such as study builds and data delivery, ultimately allowing for more efficient clinical development.

Leadership Insights

Peter Gassner, founder and CEO of Veeva, expressed enthusiasm about this collaboration. He noted, “We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall.”

Similarly, Ari Bousbib, chairman and CEO of IQVIA, stated, “Our partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients. This will enable clients on Veeva platforms to accelerate clinical development and improve access to innovations for patients.”

These statements reflect a shared vision that goes beyond mere cooperation, aiming to provide significant value to customers by enhancing operational efficiencies.

Benefits for Clients

As the global healthcare landscape continues to evolve, the partnership between IQVIA and Veeva represents a strategic advantage for clients in the life sciences industry. With streamlined workflows and enhanced functionalities, customers can expect:

• - Faster project initiation: The integration allows for quick third-party access for various projects, thereby minimizing delays in launching clinical trials or commercial efforts.
• - Better data utilization: The synergy between Veeva and IQVIA means clients can optimize their data usage across multiple platforms, ensuring more insightful analytics and decision-making.
• - Increased operational efficiencies: By combining resources and technology, the partnership is set to reduce redundancies and improve the overall execution of clinical and commercial initiatives.

The Future of Life Sciences

As both companies move forward with their strategic partnership, the emphasis will remain on innovation and customer success. The broader implication of this collaboration extends beyond enhanced clinical trials and commercial efficiencies; it symbolizes a shift towards more integrated and technology-driven healthcare solutions.

With a combined workforce passionate about life sciences, data science, and advanced technology, IQVIA and Veeva are poised to lead the charge in redefining healthcare delivery models and accelerating the journey from laboratory to market.

To learn more about this influential partnership, visit Veeva’s Partnerships and IQVIA's Partnerships.

By aligning their goals and resources, IQVIA and Veeva Systems aim to build a future where patient care is paramount, innovation is ubiquitous, and operational challenges are addressed swiftly. As the life sciences industry continues to advance, this partnership stands as a testament to how collaboration can pave the way for improved patient outcomes and efficiency in healthcare services.